Introduction {#s1}
============

Osteoarthritis (OA) is a progressive disease of the joint tissues, characterized by cartilage degradation (Goldring and Goldring, [@B30]; Loeser et al., [@B47]), mild synovial inflammation (Scanzello and Goldring, [@B68]), subchondral bone sclerosis, osteophyte formation, and calcium crystal deposition (calcification) on cartilage (McCarthy and Cheung, [@B49]). Several OA risk factors have been identified including joint trauma, aging, sex, genetics, obesity (Abramson and Attur, [@B1]), and basic calcium phosphate (BCP) crystals in joints (McCarthy and Cheung, [@B49]). BCP crystals include octacalcium phosphate (OCP), hydroxyapatite (HA), and carbonated-apatite (CA) crystals (Ea and Liote, [@B19]), the latter being the most abundant (Gibilisco et al., [@B26]). Although OA is the most common form of joint disease and a leading cause of disability in the elderly (Goldring, [@B29]), no drug exists to slow the progression, or reverse the OA disease process (Iqbal and Fleischmann, [@B36]).

There is evidence that articular tissues in OA produce proinflammatory cytokines such as IL-1 and IL-6. IL-6 is synthesized and secreted in an active form, which binds first to its receptor (IL-6R) and then to the signaling gp130 molecule triggering STAT and ERK pathways. In contrast, both IL-1α and IL-1β exist as an intracellular proform of about 31 kDa, which can be cleaved to a mature form of 17 kDa. In particular, a first signal (such as TLR1/2 agonist PAM3Cys or TLR4 agonist LPS) is needed to trigger an NF-kB--dependent production of pro--IL-1β. A second signal (ATP, BCP crystals, and others) then leads to the assembly and oligomerization of the NLRP3 inflammasome composed of the NLRP3 sensor, the adaptor protein ASC (Apoptosis-associated speck-like protein containing a CARD) and procaspase-1 which is activated in caspase-1 (Broz and Dixit, [@B9]). Caspase-1 and NLRP3 inflammasome facilitate or are needed for proIL-1β proteolytic processing and release (Gross et al., [@B34]), but pro-IL-1α is mainly processed by calpain and other proteases (Di Paolo and Shayakhmetov, [@B18]). Cellular activation due to signaling through the IL1-R1 occurs when either IL-1α and/or IL-1β (which are equally potent cytokines, collectively known as IL-1) bind to the widely expressed IL-1R type 1 (IL-1R1). Binding induces the formation of a high-affinity complex with the IL-1R accessory protein (IL-1RAcP) and the recruitment of the intracellular adaptor protein myeloid differentiation factor 88 (MyD88) and of the IL-1R-associated kinase 1 (IRAK), which are the proximal mediators of IL-1 signaling. Uncontrolled activation of IL-1R1 is prevented by two distinct mechanisms. One is mediated by IL-1Ra that competes with IL-1 for binding to IL-1R1, and blocks intracellular signaling and cell activation. The other is via the type 2 IL-1 decoy receptor (IL-1R2) that acts as a trap for IL-1 but, in contrast to IL-1R1, lacks a cytoplasmic domain and is unable to induce signaling (Re et al., [@B63]).

*In vitro*, in joints cells (such as fibroblasts, macrophages, chondrocytes, osteoblasts), IL-6 and IL-1 are responsible for the loss of cell metabolic homeostasis by 1-promoting autocrine induction of cytokines or production of other inflammatory compounds or chemokines, 2-inducing matrix-degrading enzymes such as MMP-1,-3,-9,-13, and -14 and ADAMTS4,5, and 9 (Murphy and Nagase, [@B51]; Hashizume and Mihara, [@B35]; Wojdasiewicz et al., [@B74]) and, 3-inhibiting the expression of a number of genes, such as collagen type 2 gene (Col2a1) (Goldring et al., [@B31]; Poree et al., [@B61]), and proteoglycan (van Beuningen et al., [@B72]; Sui et al., [@B70]), normally associated to healthy chondrocytes. Additionally, both IL-1 and IL-6 have pro-mineralizing activity in chondrocytes (Johnson et al., [@B39]; Nasi et al., [@B55]). Finally IL-1β and IL-6 exert their catabolic effect also in bone, by inducing differentiation of mononuclear precursors in osteoclasts (Jandinski, [@B37]; Nakamura and Jimi, [@B52]; Kim et al., [@B42]) and by stimulating bone resorption activity by osteoclasts via the receptor-activator of NF-kB ligand (RANKL) (Jules et al., [@B41]). Altogether, these *in vitro* effects of IL-1 and IL-6 strongly suggest that these cytokines should have a deleterious role in OA progression *in vivo*, inducing synovitis, favoring cartilage degradation by both catabolic and anabolic effects, and promoting cartilage calcification.

In synovial fluids of either human or experimental models of OA, both cytokines were found to be increased and correlated with radiographic knee OA (Livshits et al., [@B46]; McNulty et al., [@B50]). However, IL-1 was not significantly overexpressed in moderate OA compared to mild OA (McNulty et al., [@B50]). In experimental murine OA, IL-6 neutralization, its genetic deficiency or inhibition of its signaling molecule Stat3 with a non-peptidic small molecule prevented cartilage damage (Ryu et al., [@B66]; Latourte et al., [@B45]). In addition, in menisectomized mice, increasing deposits of BCP-crystals were observed around the joint and correlated with cartilage degradation and IL-6 expression (Nasi et al., [@B55]). While most of the studies clearly report a deleterious role of IL-1 in *in vitro* models of OA, many discrepancies exist about IL-1 effects and IL-1 blockade in experimental OA (see summary in **Table 2**). In particular, using genetically deficient mice, Glasson et al. reported that IL1β^−/−^ mice were protected in a surgical induced instability model of OA (Glasson, [@B27]), whereas Clements found in a similar model that cartilage damage was exacerbated in Caspase1^−/−^ and IL1β^−/−^ mice (Clements et al., [@B14]). More recently, in the collagenase-induced model of OA (CiOA), IL-1αβ^−/−^ mice were not protected against synovial inflammation and cartilage destruction if compared to WT mice. Moreover, intra-peritoneal injection of IL-1Ra in WT osteoarthritic mice did not ameliorate OA features (van Dalen et al., [@B73]).

Due to the confusing published results concerning the role of IL-1 in experimental models of OA, we have further reexplored its role and the role of NLRP3 inflammasome in IL-1 activation in the context of surgically induced murine OA.

Methods {#s2}
=======

Mice and induction of experimental osteoarthritis
-------------------------------------------------

IL-1α^−/−^, IL-1β^−/−^, and NLRP3^−/−^ female mice, all in the C57Bl/6J background (obtained by Prof Fabio Martinon, Epalinges, Switzerland), were compared with WT littermates. Body weight, fertility and viability were similar among different genotypes. Mice between 8 and 10 weeks were anesthetized and knee joint instability was induced surgically by medial partial meniscectomy of the right knee, as previously described (Nasi et al., [@B53]). The contralateral knee joint was sham-operated and used as internal control. The animals were allowed unrestricted activity, food and water *ad libitum* in a pathogen-free housing facility. This study was carried out in accordance with the guidelines set by the "Service de la consommation et des affaires vètèrinaires du Canton de Vaud." The protocol was approved by the Federal Veterinary Office and the work complied with the Directive 2010/63/EU.

Histology of total knee joints
------------------------------

Total knee joint of mice were fixed, decalcified and embedded in paraffin, and sagittal sections were cut from the whole medial compartment of the joint (three sections/mouse) as previously described (Nasi et al., [@B53]). Sections were then stained with Safranin-O-fast green to examine the OA-like cartilage and bone changes according to the scoring method recommended by OARSI (Glasson et al., [@B28]). Finally, synovial inflammation was scored using the following scale: 0=no inflammation; 1=mild inflammation; 2=moderate inflammation; 3 = major inflammation. Synovial histological changes included synovial hypertrophy and hyperplasia and an increased number of lining cells, accompanied sometimes by infiltration of the sublining tissue. Histological scorings were assessed by two observers who were blinded with regard to the mice genotypes.

MicroCT-scan
------------

MicroCT-scans analysis were performed using a SkyScan 1076® X-ray μCT scanning system (SkyScan, Belgium) and the following parameters: 18 μm resolution, 60 kV, 167 μA, 0.4° rotation step over 360°, 0.5 mm Aluminum filter, 1180 ms exposure time. *Ex vivo* samples acquisition was made using formol fixed knees. Images were reconstructed using NRecon Version 1.6.6.0 (Skyscan, Belgium) considering the following parameters: gray-values = 0.0000--0.105867, Ring Artifact Reduction = 3, Beam Hardening Correction = 40%. In the menisectomized knees, quantitative analyses of crystal content (μg), and quantitative analysis of tibial subchondral bone parameters (bone mineral density (BMD g/cm^3^), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular spacing (Tb.Sp) were performed using CTAnalyzer Version 1.10 (SkyScan, Belgium) for different Volumes Of Interest (VOIs).

Immunohistochemical detection of VDIPEN, type II collagen and apoptosis
-----------------------------------------------------------------------

MMP-induced neoepitope VDIPEN staining was performed with affinity-purified anti-VDIPEN IgG and type II collagen synthesis was evaluated using an anti-collagen type II, biotinylated monoclonal antibody (MD Bioproduct, 1041007B) (Nasi et al., [@B53]). Apoptotic chondrocytes were detected in paraffin sections using the Apoptag kit (ApopTag plus Peroxidase *In situ*, Millipore) as previously described (Nasi et al., [@B53]).

Calcium phosphate crystals
--------------------------

Hydroxyapatite (HA) crystals were synthesized as previously published (Prudhommeaux et al., [@B62]). HA crystals were sterilized by gamma-radiation and assessed as pyrogen-free. Prior to experimentation, crystals were resuspended in sterile PBS and sonicated for 5 min.

Bone marrow derived macrophage (BMDM) preparation
-------------------------------------------------

Bone marrow cells were isolated from the tibia and femur of C57BL/6 mice. For their differentiation into BMDM, the extracted cells were incubated for 7 days in Petri dishes with 30% L929 conditioned media (source of M-CSF) and 20% FBS in Dulbecco\'s Modified Eagle Media (DMEM). The resulting BMDM were detached using cold PBS, plated in complete DMEM medium (Gibco), \[10% FBS and 1% Penicillin Streptomycin (Sigma)\] or incomplete DMEM (1% Penicillin Streptomycin only) and primed or not with 100 ng/ml PAM3Cys overnight. The following day, crystal stimulation was performed in incomplete DMEM.

Joint chondrocyte (CHs) preparation
-----------------------------------

Chondrocytes were isolated from new-born C57Bl/6J mice as described previously, with slight modifications (Gosset et al., [@B32]). Briefly, the joint cartilage (articular and epiphyseal) was harvested from the knee and hip joints of mice aged between 4 and 6 days. The cartilage was degraded by a three step digestion process by using decreasing concentrations of Liberase (Roche). The day after, the digested tissue was passed through a 70 μm filter (BD biosciences) to obtain immature chondrocytes. The cells were plated into a culture plate at high density (3.5 × 10^4^ cells/cm^2^) and amplified for 7 days in complete DMEM (10% FBS, 1% Penicillin Streptomycin). Prior to crystal stimulation experiments, cells were detached using Trypsin-EDTA (Amimed). The resulting chondrocytes were plated in complete DMEM medium (Gibco), \[10% FBS and 1% Penicillin Streptomycin (Sigma)\] or incomplete DMEM (1% Penicillin Streptomycin only) and primed or not with 100 ng/ml PAM3Cys overnight. The following day, crystal stimulation was performed in incomplete DMEM. For chondrocyte mineralization analysis, cells were cultured for 7 days in complete BJGb medium (Gibco) (10% FBS, 50 μg/ml ascorbic acid, 20 mM β-glycerol phosphate), stimulated or not with 10 ng/ml of IL-6 (Gibco PMC0064) or with 1 ng/ml IL-1β (Gibco PMC0814). Medium was changed for the last 4 days.

Calcium phosphate crystal stimulation
-------------------------------------

Cells were primed overnight with100 ng/ml Pam3Cys, where indicated, and stimulated with 500 μg/ml HA crystals. Supernatants were collected for cytokine ELISAs, and cells placed in TRIZOL for RT-PCR analysis.

Crystal detection from chondrocyte cultures
-------------------------------------------

Articular chondrocytes cultured for 7 days were washed in PBS and crystal deposition analyzed as previously described (Gregory et al., [@B33]).

PCR analysis
------------

RNA was extracted and PCR or qRT-PCR with gene specific primers (Table [1](#T1){ref-type="table"}) was performed as previously described (Ea et al., [@B20]).

###### 

Gene specific primers for PCR and qRT-PCR analysis.

  **Gene**   **Forward primer (5′ → 3′)**        **Reverse primer (5′ → 3′)**
  ---------- ----------------------------------- -----------------------------------
  *Asc*      CCA GTG TCC CTG CTC AGA GT          TCA TCT TGT CTT GGC TGG TG
  *Casp1*    CCG TGG AGA GAA ACA AGG AG          ATG AAA AGT GAG CCC CTG AC
  *Gapdh*    CTC ATG ACC ACA GTC CAT GC          CAC ATT GGG GGT AGG AAC AC
  *Il-1b*    CCA CCA ACA AGT GAT ATT CTC CAT G   GTG CGG TCT TTC ATT ACA CAG
  *Nlrp3*    TGC TCT TCA CTG CTA TCA AGC CCT     ACA AGC CTT TGC TCC AGA CCC TAT
  *Tbp*      CTT GAA ATC ATC CCT GCG AG          CGC TTT CAT TAA ATT CTT GAT GGT C

Cytokine quantification
-----------------------

Supernatants were assayed using murine IL-1β and IL-6 ELISA kit (eBioscience) following the manufacturer\'s protocol. Results were read at 450 nm using the Spectrax M5e (Molecular devices).

Statistical analysis
--------------------

*In vitro* experiments were performed using pools of primary cells from at least 3 different mice (either chondrocytes or bone marrow derived macrophages). Moreover, all experiments were performed with triplicates and reproduced independently at least two times. Statistical analysis was performed using the Student\'s *t*-test or one- or two-way ANOVA test corrected with *post-hoc* tests for multiple comparisons, where appropriate. Data was analyzed with GraphPad Prism software (GraphPad, San Diego).

Results {#s3}
=======

IL-1α^−/−^, IL-1β^−/−^, and NLRP3^−/−^ mice are not protected against cartilage damage and synovial inflammation induced by menisectomy
---------------------------------------------------------------------------------------------------------------------------------------

At 8 weeks after surgery, sham-operated knee joints showed intact cartilage with smooth cartilage surfaces and conserved proteoglycan (PGs) staining in both tibia and femur (Figure [1A](#F1){ref-type="fig"}). Chondrocytes organization was typical of that of healthy cartilage, with one or two layers of flat cells in the superficial zone and columns of round cells in the middle and deep zones. By contrast, operated knees (MNX) from WT mice exhibited cartilage damage, PGs loss and disorganized chondrocytes arrangement. In IL-1α^−/−^, IL-1β^−/−^, and NLRP3^−/−^ menisectomized mice, cartilage degradation was evidenced and similar (for IL-1α^−/−^) or more pronounced (for IL-1β^−/−^ and NLRP3^−/−^) to that of WT mice (Figure [1A](#F1){ref-type="fig"}). We also observed in all mice genotypes, chondrocyte morphology changes, chondrocytes loss in the superficial and intermediate cartilage layers, and chondrocytes hypertrophy in the deep zone.

![IL-1α^−/−^, IL-1β^−/−^, and NLRP3^−/−^ mice develop OA features similar to WT mice after menisectomy. **(A)** Representative histologies, stained with Safranin-O, and **(B)** respective histological scoring of sham operated (WT SHAM) and menisectomized (WT MNX, IL-1α^−/−^ MNX, IL-1β^−/−^ MNX and NLRP3^−/−^ MNX) knee joint sections, at 8 weeks after surgery. Note the similar level of cartilage destruction and loss of proteoglycans in WT and IL-1α^−/−^ menisectomized knees, and exacerbated cartilage damage in IL-1β^−/−^ and NLRP3^−/−^ MNX mice. **(C)** Representative histologies, stained with Safranin-O, and **(D)** respective synovial inflammation scoring of sham operated and menisectomized knee joint sections. Note the similar level of synovial inflammation in mice of different genotypes. Mice number: WT MNX *n* = 10, IL-1α^−/−^ MNX *n* = 5, IL-1β^−/−^ MNX *n* = 5, and NLRP3^−/−^ MNX *n* = 9. ^\*^*p* \< 0.05.](fphar-08-00282-g0001){#F1}

We then scored the histological sections and found that the severity (grade) and the extent (stage) of cartilage degradation were similar between WT and IL-1α^−/−^, but significantly increased in IL-1β^−/−^ knees, both for the tibia and the femur cartilage (Figure [1B](#F1){ref-type="fig"}). Femur cartilage in NLRP3^−/−^ mice was similarly damaged but tibial cartilage was significantly increased if compared to that of WT mice (Figure [1B](#F1){ref-type="fig"}). Finally, levels of Safranin-O loss were similar amongst the genotypes, indicating similar levels of PG loss in cartilage of these mice. Altogether these results demonstrate that a single deficiency of IL-1α, IL-1β, or of NLRP3 does not prevent cartilage damage.

We next examined synovial inflammation in sham operated and MNX mice. We found mild synovial inflammation in all WT menisectomized mice compared to sham-operated. We also found similar synovial inflammation in IL-1α^−/−^, IL-1β^−/−^, and NLRP3^−/−^ MNX mice (Figure [1C](#F1){ref-type="fig"}). Synovial histological features induced by OA development included synovial hypertrophy and hyperplasia. Figure [1D](#F1){ref-type="fig"} shows the synovial inflammation score, which confirmed no significant differences between genotypes.

NLRP3^−/−^, IL-1α^−/−^, and IL-1β^−/−^ mice are not protected against catabolic changes and chondrocyte apoptosis induced by menisectomy
----------------------------------------------------------------------------------------------------------------------------------------

Signs of cartilage catabolism, in particular of MMP-mediated aggrecan degradation, were evidences by VDIPEN staining. MMP-generated neoepitopes were markedly increased in WT MNX knees if compared to that of sham-operated mice, especially in the middle and deep zones of cartilage (Figure [2A](#F2){ref-type="fig"}). Moreover, both chondrocytes and pericellular matrix were associated with marked VDIPEN neoepitope immunostaining in a comparable way in WT, and NLRP3^−/−^, IL-1α^−/−^, and IL-1β^−/−^ operated mice (Figure [2A](#F2){ref-type="fig"}).

![Knock-out mice are not protected against catabolic changes and chondroptosis caused by OA induction. **(A)** Representative immunohistochemical sections of knee joints, stained for MMP-mediated proteoglycan degradation (VDIPEN staining). Note markedly increased VDIPEN in MNX knees if compared to sham-operated mice and no protection in knock-out mice. **(B)** Representative immunohistochemical sections of knee joints, stained with anti collagen type 2 antibody. Note increased collagen type 2 synthesis in the superficial and deep cartilage layers of MNX mice compared to the sham operated mice and the similar expression of collagen type 2 in WT and KO menisectomized knees. **(C)** Representative immunohistochemical sections of knee joints, stained with ApopTag. Note increased apoptosis in MNX mice compared to sham operated mice and the similar level of chondrocyte aptosis in WT and KO menisectomized knees. Mice number: WT MNX *n* = 4, IL-1α^−/−^ MNX *n* = 4, IL-1β^−/−^ MNX *n* = 4, and NLRP3^−/−^ MNX *n* = 4.](fphar-08-00282-g0002){#F2}

In addition to catabolic signs, also anabolism and in particular collagen type 2 immunostaining has been investigated. Our observations identified weak but homogeneous extracellular distribution of collagen type 2 in sham-operated mice (Figure [2B](#F2){ref-type="fig"}). On the contrary, osteoarthritic joints showed sites of activated collagen type 2 synthesis, in a similar way in WT and KO mice. Even if subtle differences were seen in collagen type 2 expression between the different KO mice, positivity was overall detected at a similar level and especially in the superficial damaged region as well as in the deeper layer close to the tidemark with the bone. Another prominent feature of OA is increased chondrocyte apoptosis, that we tested by TUNEL staining (Figure [2C](#F2){ref-type="fig"}). Only few apoptotic chondrocytes were detected in sham-operated mice whereas an increased number of randomly distributed apoptotic chondrocytes was noticeable in menisectomized mice. Chondrocyte aptosis was similar between WT and KO mice (Figure [2C](#F2){ref-type="fig"}).

MNX IL-1β^−/−^ mice have similar knee joint calcification but increased subchondral bone osteoporosis compared with WT mice
---------------------------------------------------------------------------------------------------------------------------

We previously demonstrated that, 2 months after menisectomy, mice exhibited new calcific formation at the place of the removed meniscus (Nasi et al., [@B55]). Calcification of the joint structures is a typical OA feature, also found in human OA, and IL-1 can be a trigger of joint calcification as discussed above. We therefore examined if menisectomy-induced calcific deposits were different between WT and IL-1β^−/−^ mice. MicroCT-scan examination conducted 8 weeks after surgery revealed similar joint calcification (Figure [3A](#F3){ref-type="fig"}, white circles) and crystal content (Figure [3B](#F3){ref-type="fig"}) between the two mice genotypes, suggesting that the lack of IL-1β did not protect against ectopic mineralization induced by joint instability. Moreover, analysis of subchondral trabecular bone parameters revealed that IL-1β^−/−^ mice have similar tibial bone mineral density (BMD) and trabecular thickness (Tb.Th) to WT mice. However, they showed significantly decreased trabecular number (Tb.N) and increased trabecular separation (Tb.Sp), suggesting a high subchondral bone remodeling with increased bone resorption (Chiba et al., [@B13]) (Figure [3C](#F3){ref-type="fig"}).

![Calcific deposits and tibial subchondral trabecular bone parameters in osteoarthritic knee joints of WT and IL-1β^−/−^ mice. **(A)** Micro-CT scan images of menisectomized murine knee joints 2 months after surgery. White circles show new periarticular crystal deposits in menisectomized knees. **(B)** Crystal content in the menisectomized knees and **(C)** tibial subchondral trabecular bone parameters were measured in the same animals using CTAnalyzer. Mice number: WT *n* = 5, IL-1β^−/−^ *n* = 5. ^\*^*p* \< 0.05; ^\*\*\*^*p* \< 0.001.](fphar-08-00282-g0003){#F3}

IL-1β induces chondrocyte mineralization, but mineralization does not induce IL-1β secretion
--------------------------------------------------------------------------------------------

We previously demonstrated that BCP crystals stimulated IL-6 secretion by murine chondrocytes. Conversely, exogenous IL-6 promoted chondrocyte mineralization, thus building an amplification loop leading to OA (Nasi et al., [@B55]). We hypothesized that the absence of IL-1 effect in the MNX model could be due to the absence of this amplification loop. To test this hypothesis, we stimulated primary murine chondrocytes (CHs) with exogenous IL-1β. After 7 days of culture, calcium containing crystals, detected by Alizarin red staining were significantly increased compared to unstimulated cells (Figure [4A](#F4){ref-type="fig"}). As a positive control, we used IL-6 incubated for 7 days, which showed an even stronger promineralizing activity (Figure [4A](#F4){ref-type="fig"}). We next stimulated primed CHs and BMDM with HA crystals. In these conditions, chondrocytes did not secrete mature IL-1β, but an abundant secretion of IL-6 could be detected. By contrast, increased levels of IL-1β and IL-6 were measurable in HA-stimulated BMDM (Figure [4B](#F4){ref-type="fig"}). To explain the ELISA results, we analyzed the effect of the PAM3Cys priming on IL-1β and IL-6 genes. qRT-PCR analysis revealed that PAM3Cys strongly induced *IL-1*β gene expression in BMDM, but only marginally in CHs, whereas priming had an opposite effect on *IL-6* gene expression, being strongly up-modulated in CHs, but almost not in BMDM (Figure [4C](#F4){ref-type="fig"}). Therefore, the lack of IL-1β detection in primed CHs, under basal and HA-stimulated conditions, could be due to lower *IL-1*β gene expression in CHs (35\<Ct\<40) compared to BMDM (28\<Ct\<30). Additionally, the absence of IL-1β detection could also be accounted for by lower expression of NLRP3 inflammasome components in CHs compared to BMDM (Figure [4D](#F4){ref-type="fig"}). Our results are in agreement with already reported lower NLRP3 inflammasome expression in human OA chondrocytes and synoviocytes compared to the monocytic THP1 (Jin et al., [@B38]).

![Murine primary chondrocytes express the components of the NLRP3 inflammasome but do not produce IL-1β upon HA crystal stimulation. **(A)** Alizarin red staining and quantification in murine chondrocytes culture, stimulated or not with 5 ng/ml IL-1β or with 10 ng/ml IL-6 for 7 days in BGJb medium. Values represent means ± *SD* of triplicates from one representative experiment out of three. **(B)** IL-1β and IL-6 secretion by primed CHs or by BMDM, stimulated (black bars) or not (white bars) with HA crystals for 6 h. Values represent means ± *SD* of triplicates from one representative experiment out of three. **(C)** qRT-PCR analysis of the indicated genes in CHs and BMDM stimulated (black bars) or not (white bars) with 100 μg/ml PAM3Cys for 2 h. Results are expressed as the fold increase of gene expression in PAM3Cys treated over not treated (Nt) cells, using the mean ± *SD* of triplicate independent RNA samples. **(D)** Gel electrophoresis for the analysis of Caspase-1, Asc and Nlrp3 expression in primary murine chondrocytes (CHs) and primary bone marrow derived macrophages (BMDM). Minus (-) is the negative control (water). All experiments were performed using pools of primary cells from at least 3 different mice. ^\*\*^*p* \< 0.01, ^\*\*\*^*p* \< 0.001, ^\*\*\*\*^*p* \< 0.0001.](fphar-08-00282-g0004){#F4}

Discussion {#s4}
==========

As *in vitro* IL-1 stimulation of joint cells led to inflammation, catabolism and oxidative stress, and IL-1 blockade by IL-1Ra or IL-1R2 reverted these IL-1-induced deleterious effects (Roessler et al., [@B65]; Attur et al., [@B3], [@B2]; Palmer et al., [@B57], [@B58]), it has been suggested for more than two decades that *in vivo* IL-1 could be of paramount significance in OA (Fernandes et al., [@B22]). In the present study, we demonstrated that IL-1β^−/−^ and NLRP3^−/−^ mice were not protected against cartilage damage and synovial inflammation induced by menisectomy. Rather, cartilage damage was exacerbated by these deficiencies, thereby confirming previous results obtained in a similar MNX model, in which cartilage was more damaged in IL-1β^−/−^ and caspase-1^−/−^ mice compared to WT mice (Clements et al., [@B14]). The mechanisms explaining the protective role of IL-1β and NLRP3 inflammasome on cartilage in the surgically induced model of OA remain to be explored. We also reported here that IL-1α is not involved in cartilage damage and synovial inflammation as, in the MNX model, the phenotype of IL-1α^−/−^ was similar to that of WT mice. In agreement with the lack of a protective role of IL-1 deficiency in experimental OA, in another model of experimental OA, the collagenase-induced model of OA, mice deficient for both IL-1α and IL-1β (IL-1αβ^−/−^) developed cartilage destruction and synovial inflammation similar to WT mice (van Dalen et al., [@B73]). Interestingly, histological scoring of the cartilage lesion showed a trend toward increased damage in IL-1 deficient mice, although this increase did not reach significancy. The lack of a pathogenic role of IL-1 has been further confirmed in the collagenase-induced model by the lack of effect of IL-1Ra treatment in WT osteoarthritic mice (van Dalen et al., [@B73]). We previously reported that intra-articular BCP crystals can elicit synovial inflammation and cartilage degradation suggesting that BCP crystals have a direct pathogenic role in OA. We also found that these effects are independent of IL-1 and NLRP3 inflammasome, as knee joint inflammation and damage was similar in crystal-injected IL-1α^−/−^, IL-1β^−/−^, ASC^−/−^, or NLRP3^−/−^ mice and as IL-1Ra treatment did not prevent OA features of WT mice (Ea et al., [@B20]). Finally, the fact that deficiency of MyD88, the adaptor molecule for IL-1R1, did not impact on the severity of experimental OA strongly suggests that IL-1 is not a key mediator in the development of OA (Nasi et al., [@B53]). Altogether our results strongly suggest that IL-1 is not involved in cartilage degeneration in murine models of OA. By contrast, in a spontaneous model of OA characterized by joint calcification (Ank^−/−^ model), NLRP3 inflammasome deficiency partially (\~30%) protected against joint pathology (Jin et al., [@B38]). However, no proof of IL-1 involvement was provided in this study. Of note, one single report claimed that IL-1β^−/−^ mice had reduced cartilage erosion, but the number of mice and detailed procedures used to reach this conclusion were not mentioned and therefore caution should be taken when quoting this work (Glasson, [@B27]).

In non-murine experimental models of OA the role of IL1-mediated pathway seemed to be deleterious (see Table [2](#T2){ref-type="table"} for a summary of the works published). In the transection of the anterior cruciate ligament (ACL) dog model of OA, recombinant human interleukin-1-receptor antagonist (rHuIL-1Ra) either injected intra-articularly or locally expressed by synovial cells transduced with HuIL-1Ra gene protected against OA lesions, partially via a reduction of collagenase-1 expression (Caron et al., [@B10]; Pelletier et al., [@B60]). Similarly, in rabbit and equine surgically-induced models of OA, intra-articular overexpression of IL-1Ra resulted in a significant improvement in disease activity, cartilage degradation and synovitis (Fernandes et al., [@B23]; Frisbie et al., [@B24]). In a spontaneous model of OA (aged Hartley guinea pigs), diminished IL-1 signaling by RNA interference-based reduction (siIL-1β), or by mILRa led to decreases expression of mediators implicated in OA pathogenesis such as IL-1β, TNF-α, IL-8, INF-γ, MMP-13, and increased TGF-β1 (Santangelo et al., [@B67]). Finally, in a murine model of post-traumatic arthritis induced by articular fracture, intra-articular inhibition of IL-1 by IL-1Ra exerted protective effects in terms of cartilage degradation and synovial inflammation (Furman et al., [@B25]).

###### 

Summary of studies in animal models of OA where IL-1 role has been tested.

  **Species**   **Model**                         **Conditions**                                                                        **Duration of experiment**   **Conclusion about IL-1 role in OA**   **Citation**
  ------------- --------------------------------- ------------------------------------------------------------------------------------- ---------------------------- -------------------------------------- ---------------------------
  Dog           ACL transection                   I.a injection of 4 mg rHuIL-1Ra, at the moment of surgery                             4 weeks                      Deleterious                            Caron et al., [@B10]
  Dog           ACL transection                   I.a injection of autologous synoviocytes transduced with HuIL-1Ra, 2d post-surgery    4 weeks                      Deleterious                            Pelletier et al., [@B60]
  Rabbit        Partial medial menisectomy        Three i.a injection at 24 h intervals of 1,000 μg DogIL-Ra plasmid, 4w post-surgery   8 weeks                      Deleterious                            Fernandes et al., [@B23]
  Horse         Osteochondral fragment            I.a injection of 20 × 10^10^ VP AdEqIL-1Ra, 2w post-surgery                           10 weeks                     Deleterious                            Frisbie et al., [@B24]
  Guinea pig    Spontaneous                       I.a injection of 10^12^ DRPs siIL-1β, at 8w of age                                    24 weeks                     Deleterious                            Santangelo et al., [@B67]
                                                  I.a injection of 2x10^11^ IFUs mAd-IL-1Ra, at 8w of age                               24 weeks                     Deleterious                            
  Mouse         Destabilization medial meniscus   IL-1β^−/−^ mice                                                                       8 weeks                      Deleterious                            Glasson, [@B27]
  Mouse         Ank^−/−^                          Caspase-1^−/−^ mice                                                                   12 weeks                     Deleterious                            Jin et al., [@B38]
                                                  NLRP3^−/−^ mice                                                                                                                                           
  Mouse         Articular fracture of the knee    IL-1Ra administration intra-articularly or sistemically                               4 weeks                      Deleterious                            Furman et al., [@B25]
  Mouse         I.a injection of BCP crystals     IL-1α^−/−^, IL-1β^−/−^, ASC^−/−^, NLRP3^−/−^ mice                                     4, 17, 30 days               No role No role                        Ea et al., [@B20]
                                                  IL-1Ra                                                                                4 days                                                              
  Mouse         Partial medial menisectomy        IL-1β^−/−^ mice                                                                       4 weeks                      Protective                             Clements et al., [@B14]
                                                  Caspase-1^−/−^ mice                                                                   4 weeks                      Protective                             
  Mouse         Partial medial menisectomy        MyD88^−/−^ mice                                                                       8 weeks                      No role                                Nasi et al., [@B53]
  Mouse         Partial medial menisectomy        IL-1α^−/−^ mice                                                                       8 weeks                      No role                                This study
                                                  IL-1β^−/−^ mice                                                                       8 weeks                      Protective                             
                                                  NLRP3^−/−^ mice                                                                       8 weeks                      Protective                             
  Mouse         Collagenase-induced               IL-1αβ^−/−^ mice                                                                      4 weeks                      No role                                van Dalen et al., [@B73]
                                                  rIL-1Ra administration at the moment of the surgery and for 2w                        2 weeks                                                             

The conflicting results about the role of IL-1, but also other cytokines such as IL-6 (de Hooge et al., [@B16]; Ryu et al., [@B66]; Latourte et al., [@B45]; Nasi et al., [@B55]) in experimental models of OA, could reflect species difference, differences in age and sex of the animals used, variability in the method of OA induction (different progression of joint degeneration, degrees of inflammation, degrees of unpaired loading for each experimental OA model)."

It is important to keep in mind that in the context of inflammatory arthritis, such as collagen-induced arthritis (Joosten et al., [@B40]) and antigen-induced arthritis (Kolly et al., [@B44]), IL-1 deficiency or IL-1 neutralization leads to cartilage protection. This suggests that the mechanisms involved in cartilage degradation in an inflammatory context may be dependent on IL-1 whereas in a less inflammatory setting (such as in OA) this could not be any more true.

Discordant results about the role of IL-1 in OA have been reported not only in animal studies but also in human studies. It has been reported that patients subjected to ACL transection have increased IL-1β and IL-1Ra in synovial fluid, if compared to healthy individuals, while IL-1α remained undetectable (Marks and Donaldson, [@B48]). In accordance, the expression of IL-1β in synovial membrane positively correlated with OA grade (Smith et al., [@B69]) and with joint space width (Ning et al., [@B56]), and negatively correlated with joint alignment and physical disability (Ning et al., [@B56]). Moreover, IL-1α and IL-1β expression was detected by immunohistochemical analysis in human OA cartilage, especially in early stage OA (Towle et al., [@B71]). In a study by Denoble and co-workers, IL-1β level in synovial fluid of OA patients was increased and correlated with synovial fluid uric acid. The author concluded that uric acid could be a danger signal that contributes to increasing risk for OA through inflammasome activation and subsequent IL-1β production (Denoble et al., [@B17]). On the contrary, in a study conducted at different time-points after ACL injury, synovial fluid level of IL-1β was not increased and IL-1Ra was decreased compared to healthy controls (Bigoni et al., [@B7]). In a study in symptomatic knee OA patients, plasma levels of IL-1Ra were modestly associated with the severity and progression of the disease independent of other risk factors (Attur et al., [@B4]). High innate *ex vivo* production of IL-1β and IL-1Ra by whole blood samples from OA patients was associated with an increased risk of familial OA at multiple sites (Riyazi et al., [@B64]). However, in a separate study, *ex vivo* production of IL-1β and IL-1Ra by whole blood samples were not significantly associated with progression of knee OA over a 2-year period (Botha-Scheepers et al., [@B8]).

In addition to the contrasting results about the role of IL-1 in OA obtained in a number of experimental studies *in vitro, in vivo*, and *ex vivo*, the anti-IL-1 approach in patients has not yet proven significative improvement in OA symptoms and as a disease-modifying therapy. Various treatment strategies have been tested in human such as administration of monoclonal antibodies against IL-1 or IL-1R1 to block IL-1 signaling, administration of IL-1Ra to antagonize IL-1 action, and blockade of the formation of active IL-1β. In a first double-blind, placebo controlled, multiple-dose study by Cohen and colleagues (Cohen et al., [@B15]), a monoclonal antibody (AMG108) directed against IL-1R1, therefore inhibiting both IL-1α and IL-1β activity, was administered systemically (IV or SC) to knee OA patients (KOA). AMG108-treated group did not show statistically significant improvements in pain compared with the placebo group, as shown by pain scores (Cohen et al., [@B15]). Recombinant human IL-1 receptor antagonist proteins (IRAPs) are competitive antagonists of IL-1. In placebo-controlled clinical trials conducted in KOA patients, intra-articular injection of either Anakinra or Orthokine, two available IRAPs, didn\'t lead to significantly different pain score compared to placebo-treated patients (Chevalier et al., [@B11], [@B12]; Auw Yang et al., [@B5]). In another study in KOA patients, the clinical effects of intra-articular injection of Orthokine was compared with those of hyaluronan (HA) or placedo injection (Baltzer et al., [@B6]). Preliminary results showed that the effects of Orthokine were higher than those of HA or saline in terms of pain, stiffness and joint function (about 30% improvement) (Baltzer et al., [@B6]). Further confirmation and additional studies on the mechanism of action of Orthokine (i.e., DMOAD, chondroprotective, others) are required.

From the above mentioned data obtained both in experimental and clinical OA, we can conclude that IL-1 has not yet proven to be a good target for OA. Based on previous published papers by us (Nasi et al., [@B55],[@B54]) and by others (Ryu et al., [@B66]; Latourte et al., [@B45]), we suggest that IL-6-targeted strategies could lead to new therapeutic options for OA, by interrupting the vicious circle between BCP crystal formation and IL-6 production by chondrocytes (see Figure [5](#F5){ref-type="fig"}).

![Proposed mechanism based on the obtained results. BCP crystals found in 100% of OA patients at the moment of joint replacement (Ea et al., [@B21]), can activate NLRP3 inflammasome in macrophages leading to IL-1β secretion (Pazar et al., [@B59]), but this process does not occur in chondrocytes and synovial fibroblasts (Kolly et al., [@B43]; Jin et al., [@B38]). In addition BCP crystals induce IL-6 in macrophages, fibroblasts and chondrocytes. In these latter cells, BCP crystals induce IL-6, which in turn induce mineralization, thus creating a vicious circle and a chronification of the disease. Strategies interrupting this vicious circle could ameliorate this degenerative disease.](fphar-08-00282-g0005){#F5}

This proposed mechanism, built on chondrocytes grown in monolayers and *in vivo* observations in the menisectomy model after 2 months, needs further validations using additional *in vitro* models, such 3D-models of chondrocyte cultures, and additional *in vivo* OA models, considering different experimental points and looking to different read-outs.
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MyD88

:   Myeloid differentiation primary response gene 88

IL-1α

:   Interleukin-1α

IL-1β

:   Interleukin-1β

NLRP3

:   NOD-like receptor protein-3

OA

:   Osteoarthritis

MNX

:   Medial partial menisectomy.
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